206 related articles for article (PubMed ID: 37761318)
1. Reversible Cerebral Vasoconstriction Syndrome and Raynaud's Phenomenon: Is There a Link between the Pathogeneses of Their Underlying Complex Etiology? A Case Report and Literature Review.
Alenzi F; D'Cruz DP
Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761318
[TBL] [Abstract][Full Text] [Related]
2. Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature.
Gupta S; Zivadinov R; Ramasamy D; Ambrus JL
Clin Rheumatol; 2014 Dec; 33(12):1829-33. PubMed ID: 24277114
[TBL] [Abstract][Full Text] [Related]
3. Raynaud's phenomenon in common rheumatic diseases.
Lambova SN; Kuzmanova SI
Folia Med (Plovdiv); 2006; 48(3-4):22-8. PubMed ID: 17668693
[TBL] [Abstract][Full Text] [Related]
4. A Case Report of Reversible Cerebral Vasoconstriction Syndrome in a Patient With Systemic Scleroderma.
Liu J; Guo M; Beegle RD; Miao R; Manoucheri M
Cureus; 2022 Apr; 14(4):e24364. PubMed ID: 35619870
[TBL] [Abstract][Full Text] [Related]
5. Raynaud's phenomenon and positive antinuclear antibodies as first manifestation of POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes): a case report.
Torres-Saavedra F; León-Sierra L
BMC Rheumatol; 2022 May; 6(1):26. PubMed ID: 35585632
[TBL] [Abstract][Full Text] [Related]
6. Primary care assessment of capillaroscopy abnormalities in patients with Raynaud's phenomenon.
Overbury R; Murtaugh MA; Fischer A; Frech TM
Clin Rheumatol; 2015 Dec; 34(12):2135-40. PubMed ID: 26400642
[TBL] [Abstract][Full Text] [Related]
7. Raynaud's Phenomenon: A Vascular Acrosyndrome That Requires Long-Term Care.
Klein-Weigel P; Sander O; Reinhold S; Nielitz J; Steindl J; Richter J
Dtsch Arztebl Int; 2021 Apr; 118(Forthcoming):273-80. PubMed ID: 33632387
[TBL] [Abstract][Full Text] [Related]
8. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
9. Reversible Cerebral Vasoconstriction Syndrome Following Exposure to Oleoresin Capsicum "Pepper Spray".
Thottempudi N; Kovalev D; Munder SP; Shaltoni H; Chhabra AS; Raghuram K; Patel AV
J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106006. PubMed ID: 34325271
[TBL] [Abstract][Full Text] [Related]
10. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
Stoyneva Z
Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
[TBL] [Abstract][Full Text] [Related]
11. Raynaud's phenomenon-an update on diagnosis, classification and management.
Pauling JD; Hughes M; Pope JE
Clin Rheumatol; 2019 Dec; 38(12):3317-3330. PubMed ID: 31420815
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Raynaud's phenomenon.
Herrick AL
Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
[TBL] [Abstract][Full Text] [Related]
13. [Reversible cerebral vasoconstriction syndrome: A rare pediatric cause of thunderclap headaches].
Trolliet M; Sevely A; Albucher JF; Nasr N; Hachon Lecamus C; Deiva K; Cheuret E
Arch Pediatr; 2016 Dec; 23(12):1254-1259. PubMed ID: 27639512
[TBL] [Abstract][Full Text] [Related]
14. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
[TBL] [Abstract][Full Text] [Related]
15. Raynaud's Phenomenon with Focus on Systemic Sclerosis.
Maciejewska M; Sikora M; Maciejewski C; Alda-Malicka R; Czuwara J; Rudnicka L
J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566614
[TBL] [Abstract][Full Text] [Related]
16. Post-Traumatic Raynaud's Phenomenon: A Case Report.
Cheok LJ; Ooi CK
J Emerg Med; 2017 Jun; 52(6):e237-e238. PubMed ID: 28256352
[TBL] [Abstract][Full Text] [Related]
17. Finger blood flow after the cold challenge with primary Raynaud's syndrome: a case report.
Fujii Y; Kishimoto S; Higashi Y
Eur Heart J Case Rep; 2020 Dec; 4(6):1-5. PubMed ID: 33442606
[TBL] [Abstract][Full Text] [Related]
18. Reversible cerebral vasoconstriction syndrome after levonorgestrel-releasing intrauterine device placement-Case report.
Sun RL; Chhabra A; Patel A; Shaltoni H
Headache; 2023 May; 63(5):700-704. PubMed ID: 37140063
[TBL] [Abstract][Full Text] [Related]
19. Difficulties in diagnosis and treatment of severe secondary Raynaud's phenomenon in a Cameroonian woman: a case report.
Agbor VN; Njim T; Aminde LN
J Med Case Rep; 2016 Dec; 10(1):356. PubMed ID: 27998297
[TBL] [Abstract][Full Text] [Related]
20. Isoflavones and gastrointestinal infection: Two potential triggers for reversible cerebral vasoconstriction syndrome.
Machner B; Boppel T; Münte T
Cephalalgia; 2018 Apr; 38(5):984-987. PubMed ID: 28610434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
